Cargando…

Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen

BACKGROUND: The furosemide drip (FD), in addition to improving volume overload respiratory failure, has been used to decrease fluid in attempts to decrease intra-abdominal and abdominal wall volumes to facilitate fascial closure. The purpose of this study is to evaluate the FD and the associated rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Leland H, Patel, Mayur B, Dortch, Marcus J, Miller, Richard S, Gunter, Oliver L, Collier, Bryan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391835/
https://www.ncbi.nlm.nih.gov/pubmed/22787341
http://dx.doi.org/10.4103/0974-2700.96480
_version_ 1782237556484603904
author Webb, Leland H
Patel, Mayur B
Dortch, Marcus J
Miller, Richard S
Gunter, Oliver L
Collier, Bryan R
author_facet Webb, Leland H
Patel, Mayur B
Dortch, Marcus J
Miller, Richard S
Gunter, Oliver L
Collier, Bryan R
author_sort Webb, Leland H
collection PubMed
description BACKGROUND: The furosemide drip (FD), in addition to improving volume overload respiratory failure, has been used to decrease fluid in attempts to decrease intra-abdominal and abdominal wall volumes to facilitate fascial closure. The purpose of this study is to evaluate the FD and the associated rate of primary fascial closure following trauma damage control laparotomy (DCL). MATERIALS AND METHODS: From January 2004 to September 2008, a retrospective review from a single institution Trauma Registry of the American College of Surgeons dataset was performed. All DCLs greater than 24 h who had a length of stay for 3 or more days were identified. The study group (FD+) and control group (FD-) were compared. Demographic data including age, sex, probability of survival, red blood cell transfusions, initial lactate, and mortality were collected. Primary outcomes included primary fascial closure and primary fascial closure within 7 days. Secondary outcomes included total ventilator days and LOS. RESULTS: A total of 139 patients met inclusion criteria: 25 FD+ and 114 FD-. The 25 FD+ patients received the drug at a median 4 days post DCL. Demographic differences between the groups were not significantly different, except that initial lactate was higher for FD- (1.7 vs 4.0; P=0.03). No differences were noted between groups regarding successful primary fascial closure (FD+ 68.4% vs FD- 64.0%; P=0.669), or closure within 7 days (FD+13.2% vs FD- 28.0%; P=0.066) of original DCL. FD+ patients suffered more open abdomen days (4 [2-7] vs 2 [1-4]; P=0.001). FD+ did not demonstrate an association with primary fascial closure [Odds ratio (OR) 1.5, 95% confidence interval (CI) 0.260-8.307; P=0.663]. FD+ patients had more ventilator days and longer Intensive Care Unit (ICU)/hospital LOS (P<0.01). CONCLUSION: FD use may remove excess volume; however, forced diuresis with an FD is not associated with an increased rate of primary closure after DCL. Further studies are warranted to identify ICU strategies to facilitate fascial closure in DCL.
format Online
Article
Text
id pubmed-3391835
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33918352012-07-11 Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen Webb, Leland H Patel, Mayur B Dortch, Marcus J Miller, Richard S Gunter, Oliver L Collier, Bryan R J Emerg Trauma Shock Original Article BACKGROUND: The furosemide drip (FD), in addition to improving volume overload respiratory failure, has been used to decrease fluid in attempts to decrease intra-abdominal and abdominal wall volumes to facilitate fascial closure. The purpose of this study is to evaluate the FD and the associated rate of primary fascial closure following trauma damage control laparotomy (DCL). MATERIALS AND METHODS: From January 2004 to September 2008, a retrospective review from a single institution Trauma Registry of the American College of Surgeons dataset was performed. All DCLs greater than 24 h who had a length of stay for 3 or more days were identified. The study group (FD+) and control group (FD-) were compared. Demographic data including age, sex, probability of survival, red blood cell transfusions, initial lactate, and mortality were collected. Primary outcomes included primary fascial closure and primary fascial closure within 7 days. Secondary outcomes included total ventilator days and LOS. RESULTS: A total of 139 patients met inclusion criteria: 25 FD+ and 114 FD-. The 25 FD+ patients received the drug at a median 4 days post DCL. Demographic differences between the groups were not significantly different, except that initial lactate was higher for FD- (1.7 vs 4.0; P=0.03). No differences were noted between groups regarding successful primary fascial closure (FD+ 68.4% vs FD- 64.0%; P=0.669), or closure within 7 days (FD+13.2% vs FD- 28.0%; P=0.066) of original DCL. FD+ patients suffered more open abdomen days (4 [2-7] vs 2 [1-4]; P=0.001). FD+ did not demonstrate an association with primary fascial closure [Odds ratio (OR) 1.5, 95% confidence interval (CI) 0.260-8.307; P=0.663]. FD+ patients had more ventilator days and longer Intensive Care Unit (ICU)/hospital LOS (P<0.01). CONCLUSION: FD use may remove excess volume; however, forced diuresis with an FD is not associated with an increased rate of primary closure after DCL. Further studies are warranted to identify ICU strategies to facilitate fascial closure in DCL. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3391835/ /pubmed/22787341 http://dx.doi.org/10.4103/0974-2700.96480 Text en Copyright: © Journal of Emergencies, Trauma, and Shock http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Webb, Leland H
Patel, Mayur B
Dortch, Marcus J
Miller, Richard S
Gunter, Oliver L
Collier, Bryan R
Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen
title Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen
title_full Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen
title_fullStr Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen
title_full_unstemmed Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen
title_short Use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen
title_sort use of a furosemide drip does not improve earlier primary fascial closure in the open abdomen
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391835/
https://www.ncbi.nlm.nih.gov/pubmed/22787341
http://dx.doi.org/10.4103/0974-2700.96480
work_keys_str_mv AT webblelandh useofafurosemidedripdoesnotimproveearlierprimaryfascialclosureintheopenabdomen
AT patelmayurb useofafurosemidedripdoesnotimproveearlierprimaryfascialclosureintheopenabdomen
AT dortchmarcusj useofafurosemidedripdoesnotimproveearlierprimaryfascialclosureintheopenabdomen
AT millerrichards useofafurosemidedripdoesnotimproveearlierprimaryfascialclosureintheopenabdomen
AT gunteroliverl useofafurosemidedripdoesnotimproveearlierprimaryfascialclosureintheopenabdomen
AT collierbryanr useofafurosemidedripdoesnotimproveearlierprimaryfascialclosureintheopenabdomen